Results · Apr-Jun 2026
Caprolactam Chemicals Q1 FY27 results
Sales fell 82% to ₹0.47 crore from ₹2.6 crore in Apr-Jun 2025.
Operating profit fell 142% to −₹0.45 crore, an operating margin of −95.1% (down 136.0 points from a year ago).
Net profit turned into a loss of ₹0.99 crore, from a profit of ₹0.36 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −85%, swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.5 | 2.6 | −82% |
| Operating profit (EBITDA) | -0.4 | 1.0 | −142% |
| Operating margin | −95.1% | 40.8% | −136.0 pts |
| Net profit | -1.0 | 0.4 | swings to a loss |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.